Foghorn Therapeutics develops precision medicines that target the chromatin regulatory system to correct abnormal gene expression, with a focus on cancer and other serious diseases
Foghorn Therapeutics develops precision medicines that target the chromatin regulatory system to correct abnormal gene expression, with a focus on cancer and other serious diseases.